metricas
covid
Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Non-functioning neuroendocrine tumor retrograde
Información de la revista
Vol. 44. Núm. 7.
Páginas 495-496 (agosto - septiembre 2021)
Vol. 44. Núm. 7.
Páginas 495-496 (agosto - septiembre 2021)
Image of the month
Acceso a texto completo
Non-functioning neuroendocrine tumor retrograde
Tumor neuroendocrino no funcionante retrocava
Visitas
210
Idoia Boneta,
Autor para correspondencia
idoia.bonet@gmail.com

Corresponding author.
, Santiago Sanchez-Cabúsb, Jose Antonio Gonzálezc, Antonio Morald
a Departamento de Cirugía General y Digestivo, Hospital de la Santa Creu y Sant Pau, Barcelona, Spain
b Sección de Cirugía Hepatobiliar, Hospital de la Santa Creu y Sant Pau, Barcelona, Spain
c Sección de Cirugía Endocrina y Sarcomas, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Servicio de Cirugía General, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Texto completo

Neuroendrocrine tumours are a type of epithelial neoplasm with a low incidence. They are clinically silent, subject to late diagnosis and are located primarily in the gastrointestinal tract. The only option for curing them is surgical treatment with R0 resection.1,2 We report the case of an asymptomatic patient incidentally diagnosed with a neuroendocrine tumour located in the retrocaval region, which is rare for this type of tumour. An abdominal computed tomography (CT) scan showed a well-defined retroperitoneal mass measuring 59 mm × 48 mm, caudal to the left renal vein. In addition, a left infrarenal double inferior cava was observed as an anatomical variant, so this tumour was located posterior to the right primitive iliac vein (Fig. 1).

Figure 1.

(A) Abdominal CT scan showing a retrocaval tumour (arrow). (B) Macroscopic image of the tumour after surgical removal.

(0.29MB).

An octreoscan showed a retroperitoneal mass at L2-L3 with expression of somatostatin receptors, supporting the diagnosis of a neuroendocrine tumour.

The patient underwent surgery and complete surgical resection was achieved.

The definitive pathology results were a World Health Organization (WHO) grade II neuroendocrine tumour with a maximum diameter of 51 mm, disease-free resection margins with a Ki-67 of 10%, a mitotic index of 9 mitoses per 50 high-power fields and images of neoplastic infiltration of capillaries on the periphery of the lesion with involvement of 0/5 lymph nodes.

References
[1]
A. Dasari, C. Shen, D. Halperin, B. Zhao, S. Zhou, Y. Xu, et al.
Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States.
JAMA Oncol, 3 (2017), pp. 1335-1342
[2]
B. Oronsky, P.C. Ma, D. Morgensztern, C.A. Carter.
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.
Neoplasia, 19 (2017), pp. 991-1002

Please cite this article as: Bonet I, Sanchez-Cabús S, González JA, Moral A. Tumor neuroendocrino no funcionante retrocava. Gastroenterol Hepatol. 2021;44:495–496.

Copyright © 2020. Elsevier España, S.L.U.. All rights reserved
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos